Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Nov 02 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 4 pages · English

Summary by 6ix AI

The partnership aims to enhance precision oncology by providing oncologists with tools to make informed treatment decisions based on patients' genomic profiles. This agreement reflects a commitment to improve patient outcomes and address unmet cancer treatment needs in the region.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 02, 2023, titled "Zydus and Guardant Health to jointly promote the Guardant360�� portfolio of next-generation genomic tests for advanced solid cancers in India and Nepal".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases